<DOC>
	<DOC>NCT00524498</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of a continuous hepatic arterial infusion combination therapy with OPC-18 and 5-FU versus BST in patients with highly advanced hepatocellular carcinoma for which resection therapy or local therapy is inapplicable due to advanced vascular invasion.</brief_summary>
	<brief_title>A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients who are histologically or clinically (diagnostic imaging and tumor marker) diagnosed with hepatocellular carcinoma Patients with a measurable lesion by contrast CT Patients with no remote metastasis (extrahepatic metastasis), confirmed by Xray, CT, MRI, or other means if necessary Patients who have not previously received intraarterial hepatic chemotherapy Patients receiving the herbal medicine shosaikoto Patients with autoimmune hepatitis Patients with a history of hypersensitivity to OPC18 or other interferon preparations</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>OPC-18</keyword>
	<keyword>Interferon-alpha</keyword>
	<keyword>Fluorouracil</keyword>
</DOC>